Identification of Biomarkers for the Prevention of Chronic Disease

S Boccia; Jun Liu; Ayse Demirkan; Cornelia Duijn; M Mariani; C Castagna; R Pastorino; S Fiatal; P Pikó; R Ádány; G Bottà

doi:10.1007/978-3-030-52399-2_2

Identification of Biomarkers for the Prevention of Chronic Disease

S Boccia, Jun Liu, Ayse Demirkan, Cornelia Duijn, M Mariani, C Castagna, R Pastorino, S Fiatal, P Pikó, R Ádány, G Bottà

Epidemiology

Research output: Chapter/Conference proceeding › Chapter › Academic

1 Citation (Scopus)

Abstract

One of the goals of personalised medicine (PM) is to use the ever-growing understanding of biology to provide a higher level of precision in disease prevention and patient care. PM strategies include the use of decision-making processes based on biomarker-driven approaches. Genes, gene expression products (i.e. transcripts and proteins) and metabolites are the main biomarker families. Given this molecular diversity of biomarkers, the increase in high-throughput omics technologies offers an amazing opportunity to capture the whole picture of biological systems in a hypothesis-free and unbiased model. This chapter examines as the high-throughput era in omics is progressing and as genomics and other omics will be effective in disentangling the aetiology and progression of the diseases.

Original language	English
Title of host publication	Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact
Editors	S. Boccia, R. Adany, P. Villari, M. C. Cornel, C. de Vito, R. Pastorino
Place of Publication	Springer
Publisher	[uitgever onbekend]
Pages	9-32
Number of pages	24
ISBN (Print)	9783030523985
DOIs	https://doi.org/10.1007/978-3-030-52399-2_2
Publication status	Published - 2021

Publication series

Series	SpringerBriefs in Public Health

Bibliographical note

Publisher Copyright:
© 2021, The Editor(s) and Author(s), under exclusive license to Springer Nature Switzerland AG.

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-030-52399-2_2

Cite this

Boccia, S., Liu, J., Demirkan, A., Duijn, C., Mariani, M., Castagna, C., Pastorino, R., Fiatal, S., Pikó, P., Ádány, R., & Bottà, G. (2021). Identification of Biomarkers for the Prevention of Chronic Disease. In S. Boccia, R. Adany, P. Villari, M. C. Cornel, C. de Vito, & R. Pastorino (Eds.), Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact (pp. 9-32). [uitgever onbekend]. https://doi.org/10.1007/978-3-030-52399-2_2

Boccia, S ; Liu, Jun ; Demirkan, Ayse et al. / Identification of Biomarkers for the Prevention of Chronic Disease. Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact. editor / S. Boccia ; R. Adany ; P. Villari ; M. C. Cornel ; C. de Vito ; R. Pastorino. Springer : [uitgever onbekend], 2021. pp. 9-32 (SpringerBriefs in Public Health).

@inbook{74d53f1c5512433cb16f6d8386333c04,

title = "Identification of Biomarkers for the Prevention of Chronic Disease",

abstract = "One of the goals of personalised medicine (PM) is to use the ever-growing understanding of biology to provide a higher level of precision in disease prevention and patient care. PM strategies include the use of decision-making processes based on biomarker-driven approaches. Genes, gene expression products (i.e. transcripts and proteins) and metabolites are the main biomarker families. Given this molecular diversity of biomarkers, the increase in high-throughput omics technologies offers an amazing opportunity to capture the whole picture of biological systems in a hypothesis-free and unbiased model. This chapter examines as the high-throughput era in omics is progressing and as genomics and other omics will be effective in disentangling the aetiology and progression of the diseases.",

author = "S Boccia and Jun Liu and Ayse Demirkan and Cornelia Duijn and M Mariani and C Castagna and R Pastorino and S Fiatal and P Pik{\'o} and R {\'A}d{\'a}ny and G Bott{\`a}",

note = "Publisher Copyright: {\textcopyright} 2021, The Editor(s) and Author(s), under exclusive license to Springer Nature Switzerland AG.",

year = "2021",

doi = "10.1007/978-3-030-52399-2\_2",

language = "English",

isbn = "9783030523985",

series = "SpringerBriefs in Public Health",

publisher = "[uitgever onbekend]",

pages = "9--32",

editor = "S. Boccia and R. Adany and P. Villari and \{C. Cornel\}, M. and \{de Vito\}, C. and R. Pastorino",

booktitle = "Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact",

}

Boccia, S, Liu, J, Demirkan, A, Duijn, C, Mariani, M, Castagna, C, Pastorino, R, Fiatal, S, Pikó, P, Ádány, R & Bottà, G 2021, Identification of Biomarkers for the Prevention of Chronic Disease. in S Boccia, R Adany, P Villari, M C. Cornel, C de Vito & R Pastorino (eds), Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact. [uitgever onbekend], Springer, SpringerBriefs in Public Health, pp. 9-32. https://doi.org/10.1007/978-3-030-52399-2_2

Identification of Biomarkers for the Prevention of Chronic Disease. / Boccia, S; Liu, Jun; Demirkan, Ayse et al.
Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact. ed. / S. Boccia; R. Adany; P. Villari; M. C. Cornel; C. de Vito; R. Pastorino. Springer: [uitgever onbekend], 2021. p. 9-32 (SpringerBriefs in Public Health).

Research output: Chapter/Conference proceeding › Chapter › Academic

TY - CHAP

T1 - Identification of Biomarkers for the Prevention of Chronic Disease

AU - Boccia, S

AU - Liu, Jun

AU - Demirkan, Ayse

AU - Duijn, Cornelia

AU - Mariani, M

AU - Castagna, C

AU - Pastorino, R

AU - Fiatal, S

AU - Pikó, P

AU - Ádány, R

AU - Bottà, G

PY - 2021

Y1 - 2021

N2 - One of the goals of personalised medicine (PM) is to use the ever-growing understanding of biology to provide a higher level of precision in disease prevention and patient care. PM strategies include the use of decision-making processes based on biomarker-driven approaches. Genes, gene expression products (i.e. transcripts and proteins) and metabolites are the main biomarker families. Given this molecular diversity of biomarkers, the increase in high-throughput omics technologies offers an amazing opportunity to capture the whole picture of biological systems in a hypothesis-free and unbiased model. This chapter examines as the high-throughput era in omics is progressing and as genomics and other omics will be effective in disentangling the aetiology and progression of the diseases.

AB - One of the goals of personalised medicine (PM) is to use the ever-growing understanding of biology to provide a higher level of precision in disease prevention and patient care. PM strategies include the use of decision-making processes based on biomarker-driven approaches. Genes, gene expression products (i.e. transcripts and proteins) and metabolites are the main biomarker families. Given this molecular diversity of biomarkers, the increase in high-throughput omics technologies offers an amazing opportunity to capture the whole picture of biological systems in a hypothesis-free and unbiased model. This chapter examines as the high-throughput era in omics is progressing and as genomics and other omics will be effective in disentangling the aetiology and progression of the diseases.

UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096773512&doi=10.1007%2f978-3-030-52399-2_2&partnerID=40&md5=406a65a243ee8c30565f6049bdce0e7d

UR - http://www.scopus.com/inward/record.url?scp=85096773512&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-52399-2_2

DO - 10.1007/978-3-030-52399-2_2

M3 - Chapter

SN - 9783030523985

T3 - SpringerBriefs in Public Health

SP - 9

EP - 32

BT - Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact

A2 - Boccia, S.

A2 - Adany, R.

A2 - Villari, P.

A2 - C. Cornel, M.

A2 - de Vito, C.

A2 - Pastorino, R.

PB - [uitgever onbekend]

CY - Springer

ER -

Boccia S, Liu J, Demirkan A, Duijn C, Mariani M, Castagna C et al. Identification of Biomarkers for the Prevention of Chronic Disease. In Boccia S, Adany R, Villari P, C. Cornel M, de Vito C, Pastorino R, editors, Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact. Springer: [uitgever onbekend]. 2021. p. 9-32. (SpringerBriefs in Public Health). doi: 10.1007/978-3-030-52399-2_2

Identification of Biomarkers for the Prevention of Chronic Disease

Abstract

Publication series

Bibliographical note

Research programs

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this